🔎 Trials Near Me

Domov › Disfunkcija levega prekata › Ohio

Klinične študije za Disfunkcija levega prekata v Ohio

4 študij za Disfunkcija levega prekata išče udeležence na lokacijah v Ohio.

Mesta v Ohio

Uradno besedilo študije (angleško)

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
  • Cleveland Clinic-Cleveland Clinic Chidren's ( Site 0022), Cleveland
Vključevanje udeležencevFaza 2/3
29 Days – 17 Years · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT05714085

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  • Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
  • Cleveland Clinic Children's, Cleveland
  • Nationwide Children's Hospital - Cardiology, Columbus
Vključevanje udeležencevFaza 3
Do 18 let · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT07192952

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  • Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
  • Cleveland Clinic Children's, Cleveland
  • Nationwide Children's Hospital - Cardiology, Columbus
Vključevanje udeležencevFaza 3
6 Months – 17 Years · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT07188805

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

  • University Hospitals Cleveland Medical Center, Cleveland
Vključevanje udeležencev
Starost 18 in več · Vsi spoli · Posodobljeno 28. apr. 2026 · NCT05427370

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.